OUE Lippo Healthcare to appeal Shanghai courts' judgment on Weixin claim

OUE Lippo Healthcare to appeal Shanghai courts' judgment on Weixin claim

PC Lee
21/12/17, 08:31 am

SINGAPORE (Dec 20): OUE Lippo Healthcare, the former International Healthway Corporation (IHC), says the Shanghai courts had rendered a first instance judgment in favour of Weixin Hospital Investment Management (Shanghai) Co. regarding claims to two subsidiaries under IHC.

Announced on Feb 22, the claims were against Shanghai Yi Lin Medical Management Consulting Co and Wuxi New District Phoenix Hospital Co by Weixin, a company controlled by David Lin Kao Kun.

Weixin had sought an order for Shanghai Yi Lin to transfer the shares in Wuxi to Weixin. Among other things, Weixin alleged there was a share transfer agreement between Shanghai Yi Lin and Weixin, as well as an alleged commitment letter provided by the then-shareholder and legal representative of Shanghai Yi Lin which purportedly recognised Lin as the beneficial investor for Wuxi Co and Shanghai Yi Lin.

On or around Dec 13, a judgment in favour of Weixin was issued by the Shanghai courts.

In a filing on Wednesday night, OUE Lippo Healthcare has been advised by its counsel in China there is a good chance that the judgment will be reversed on appeal. Once the appeal is filed, the judgment will have no effect and Weixin cannot be enforced.

OUE Lippo Healthcare says it has given instructions to the counsel to file and prosecute the appeal.

Shares in OUE Lippo Healthcare last traded at 12 cents.


CapitaLand Mall Trust upgraded to 'buy' by UOB on Jurong Lake District plans, Funan launch

SINGAPORE (May 27): CapitaLand Mall Trust will benefit from the development of Jurong Lake District (JLD) as it has three retail malls located within Jurong Gateway, says UOB KayHian. See: CapitaLand Mall Trust declares 3.6% higher DPU of 2.88 cents on higher income IMM Building, JCube and Westgate, which in total accounts for 20% of CMT’s portfolio valuation, are located within Jurong Gateway and adjacent to Jurong East MRT station. Meanwhile, Funan, which is about 90% pre-committed for retail space and 98% pre-committed for office space, is scheduled to open next month. See als....

Time to 'buy' MindChamps as growth initiatives bear fruit: RHB

SINGAPORE (May 27): RHB Research continues to keep MindChamps Preschool at “buy” at a lower target price of 83 cents compared to 87 cents previously, indicating a 26% upside plus 2.2% yield. The reduced target price comes after cutting FY19-20F earnings by 7% and 11%, respectively, upon management indications that adopting SFRS 16 has negatively impacted the group’s 1Q19 pre-tax profit by about $90 million or -15%. In a May 17 report, analyst Juliana Cai says she nonetheless remains positive on MindChamps as she expects the group to start reaping returns from its investments as its....

Ascendas-Singbridge establishes co-innovation lab with IMDA & Enterprise Singapore

SINGAPORE (May 27): Singapore’s smart nation ambitions have been further bolstered by a new partnership between Ascendas-Singbridge, Infocomm Development Authority of Singapore (IMDA) and Enterprise Singapore (ESG) to form the Smart Urban Co-Innovation Lab. All three parties are looking to have a total of 30 co-innovation projects come out from the lab, which is expected to be launched at the end of the year as the first developer-led lab in Southeast Asia. This announcement follows last year’s call for innovation led by IMDA, Ascendas and JTC. Ascendas has published 12 probl....